H.R. 413 · 113th Congress
To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.
- Stage
- In committee
- Sponsor
- Peter Welch
- Introduced
- 2013-01-23
- Latest action
- 2013-02-08 · Referred to the Subcommittee on Health.